MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-RJ-17-0096988
Medirovi Pharmaceutical Private Limited
Medirovi Pharmaceutical Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹12.39 Lakh
▲ 4% YoY
Net profit · FY 2025
₹31,246
Net margin 2.5%
EBITDA · FY 2025
₹1.66 Lakh
EBITDA margin 13.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Medirovi Pharmaceutical Private Limited
Data last updated:
Medirovi Pharmaceutical Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 August 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U52310DL2021PTC385019. Its GSTIN is 08AAOCM8643C1Z7 (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Maya Devi and Ravi Shankar Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A 66 Raghubir Nagar Jj Colony, Delhi, India – 110027.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.39 Lakh, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹31,246 (net margin 2.5%) and EBITDA of ₹1.66 Lakh (EBITDA margin 13.4%). Revenue has grown at a compounded annual rate (CAGR) of 62% over three years.
Medirovi Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-17-0096988).
Company details
CIN U52310DL2021PTC385019
Registration Number 385019
Incorporation Date 10 August 2021
ROC Delhi
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-RJ-17-0096988
Key People
Maya Devi Director Ravi Shankar Sharma Director Recognitions & Rankings of Medirovi Pharmaceutical
Contact details
Medirovi Pharmaceutical Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressA 66 Raghubir Nagar Jj Colony, Delhi, India – 110027
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Medirovi Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Medirovi Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Medirovi Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Medirovi Pharmaceutical Private Limited, buy the company report.
Financials of Medirovi Pharmaceutical Private Limited
FY 2025 filings availableMedirovi Pharmaceutical Private Limited reported revenue of ₹12.39 Lakh (up 4% YoY) for FY 2025.
Revenue · FY 2025
₹12.39 Lakh ▲ 4%
Net profit · FY 2025
₹31,246 margin 2.5%
EBITDA · FY 2025
₹1.66 Lakh margin 13.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 4%
3 years · compounded
▲ 62%
EBITDA CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 103%
Revenue has grown at a compounded annual rate (CAGR) of 62% over three years, including 4% growth in the latest year. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹1.66 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹31,246 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 13.4% | |||
| Net Profit Margin | 2.5% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Medirovi Pharmaceutical Private Limited, buy the company report.
Board of directors of Medirovi Pharmaceutical Private Limited
Medirovi Pharmaceutical has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Maya Devi | Director | 10 Aug 2021 | 5 Years 3 Months | Current |
| Ravi Shankar Sharma | Director | 10 Aug 2021 | 5 Years 3 Months | Current |
Peer comparison
Medirovi Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Amigos Pharmaceuticals Private Limited | ₹12.44 Lakh (FY 2019) | 11.0% | Pune, Maharashtra, India | |||
| Virag Chemicals Private Limited | ₹12.43 Lakh (FY 2025) | 9.0% | Khed, Maharashtra, India | |||
| B.U. Life Science Private Limited | ₹12.41 Lakh (FY 2025) | -64.0% | Ahmedabad, Gujarat, India | |||
| Pippli Biotech Private Limited | ₹12.41 Lakh (FY 2025) | -44.0% | Buxar, Bihar, India | |||
| Radharaman Pharma Private Limited | ₹12.39 Lakh (FY 2021) | Rajkot, Gujarat, India | ||||
| Medirovi Pharmaceutical Private Limitedthis company | ₹12.39 Lakh (FY 2025) | ₹31,246 | 2.5% | 4.0% | Delhi, India | |
| Ruby Chemicals Private Limited | ₹12.37 Lakh (FY 2025) | 141.0% | Porbandar, Gujarat, India | |||
| Viber Life Science Laboratories Private Limited | ₹12.36 Lakh (FY 2023) | Ahmedabad, Gujarat, India | ||||
| Care First Pharmaceuticals Private Limited | ₹12.36 Lakh (FY 2024) | Delhi, India | ||||
| Miyashi Life Science Private Limited | ₹12.36 Lakh (FY 2025) | -10.0% | Gautam Buddha Nagar, Uttar Pradesh, India | |||
| Jatas Herbals Limited | ₹12.36 Lakh (FY 2025) | 57.0% | Kakinada, Andhra Pradesh, India |
To see the full peer comparison of Medirovi Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medirovi Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medirovi Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Medirovi Pharmaceutical Private Limited has 1 active EPFO establishment as of Nov 12, 2026.
Active EPFO establishments
1
GST
Medirovi Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAOCM8643C1Z7 | Rajasthan | Active | 03 Sep 2021 |
To see the full GST registrations and return filing status of Medirovi Pharmaceutical Private Limited, buy the company report.
Recent activity
Medirovi Pharmaceutical Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Maya Devi was appointed as Director on 10 Aug 2021.
AGM
Medirovi Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Medirovi Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Maya Devi was appointed as Director.
Appointed
Ravi Shankar Sharma was appointed as Director.
Incorporation
10 Aug 2021
Medirovi Pharmaceutical Private Limited was registered on 10 Aug 2021 with Roc Delhi & aged 5 years 3 months as per MCA records.
Frequently asked questions
Medirovi Pharmaceutical is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 August 2021 (5+ years old) and is registered under CIN U52310DL2021PTC385019.
Medirovi Pharmaceutical has 2 current directors:
- Maya Devi - Director
- Ravi Shankar Sharma - Director
The latest financial statements of Medirovi Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Medirovi Pharmaceutical is 08AAOCM8643C1Z7, registered in Rajasthan.
The CIN (Corporate Identification Number) of Medirovi Pharmaceutical is U52310DL2021PTC385019. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medirovi Pharmaceutical was incorporated on 10 August 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Medirovi Pharmaceutical by revenue are Amigos Pharmaceuticals Private Limited, Virag Chemicals Private Limited, B.U. Life Science Private Limited, Pippli Biotech Private Limited, Radharaman Pharma Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Maya Devi was appointed as Director on 10 Aug 2021. Ravi Shankar Sharma was appointed as Director on 10 Aug 2021.
Yes, Medirovi Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-RJ-17-0096988).
The registered office of Medirovi Pharmaceutical is at A 66 Raghubir Nagar Jj Colony, Delhi, India – 110027.
Medirovi Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages